SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-16-000194
Filing Date
2016-11-14
Accepted
2016-11-14 07:44:13
Documents
3
Period of Report
2016-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebioform8kq32016earnings.htm 8-K 35446
2 EXHIBIT 99.1 q32016prvfinal.htm EX-99.1 158655
3 ebiologoa10.jpg GRAPHIC 89522
  Complete submission text file 0001485003-16-000194.txt   318393
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 161990577
SIC: 2834 Pharmaceutical Preparations